Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions

Experimental Dermatology

Volumn 20, Issue 12, 2011, Pages 980-985

  Wallbrecht, Katrin ^a   Drick, Nora ^a   Hund, Anna Carina ^a   Schön, Michael P ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Endothelial cells; Fumaric acid esters; Inflammation; Lymphocyte recruitment; Psoriasis

Indexed keywords

CD31 ANTIGEN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID ETHYL ESTER; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CELL INTERACTION; CELL POPULATION; CONTROLLED STUDY; DOWN REGULATION; DYNAMICS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE; PLEIOTROPY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PSORIASIS;

CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TRANSFORMED; CELL MEMBRANE; DOWN-REGULATION; E-SELECTIN; ENDOTHELIAL CELLS; FUMARATES; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTE ROLLING; LYMPHOCYTES; MALEATES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 81455154321     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01376.x     Document Type: Article

References (45)

1. Lowes M A, Bowcock A M, Krueger J G. Nature 2007: 445: 866-873.
2. Nestle F O, Kaplan D H, Barker J N. N Engl J Med 2009: 361: 496-509.
3. Sabat R, Philipp S, Höflich C et al. Exp Dermatol 2007: 16: 779-798.
4. Reich K, Thaci D, Mrowietz U et al. J Dtsch Dermatol Ges 2009: 7: 603-611.
5. Rostami-Yazdi M, Mrowietz U. Clin Dermatol 2008: 26: 522-526.
6. Wain E M, Darling M I, Pleass R D et al. Br J Dermatol 2010: 162: 427-434.
7. Vandermeeren M, Janssens S, Borgers M et al. Biochem Biophys Res Commun 1997: 234: 19-23.
8. Rubant S A, Ludwig R J, Diehl S et al. J Invest Dermatol 2008: 128: 326-331.
9. Lehmann M, Risch K, Nizze H et al. Arch Dermatol Res 2002: 294: 399-404.
10. Bovenschen H J, Langewouters A M, van de Kerkhof P C. Am J Clin Dermatol 2010: 11: 343-350.
11. Nieboer C, de Hoop D, van Loenen A C et al. J Am Acad Dermatol 1989: 20: 601-608.
12. Zhu K, Mrowietz U. J Invest Dermatol 2001: 116: 203-208.
13. Treumer F, Zhu K, Glaser R et al. J Invest Dermatol 2003: 121: 1383-1388.
14. Stoof T J, Flier J, Sampat S et al. Br J Dermatol 2001: 144: 1114-1120.
15. Thio H B, Zomerdijk T P, Oudshoorn C et al. Br J Dermatol 1994: 131: 856-861.
16. Ockenfels H M, Schultewolter T, Ockenfels G et al. Br J Dermatol 1998: 139: 390-395.
17. Lehmann J C, Listopad J J, Rentzsch C U et al. J Invest Dermatol 2007: 127: 835-845.
18. Schmidt M M, Dringen R. Neurochem Int 2010: 57: 460-467.
19. Schmidt T J, Ak M, Mrowietz U. Bioorg Med Chem 2007: 15: 333-342.
20. Litjens N H, Burggraaf J, van Strijen E et al. Br J Clin Pharmacol 2004: 58: 429-432.
21. Litjens N H, van Strijen E, van Gulpen C et al. BMC Pharmacol 2004: 4: 22.
22. de Jong R, Bezemer A C, Zomerdijk T P et al. Eur J Immunol 1996: 26: 2067-2074.
23. Litjens N H, Rademaker M, Ravensbergen B et al. Eur J Immunol 2004: 34: 565-575.
24. Rostami-Yazdi M, Clement B, Mrowietz U. Arch Dermatol Res 2010: 302: 531-538.
25. Rostami-Yazdi M, Clement B, Schmidt T J et al. J Invest Dermatol 2009: 129: 231-234.
26. Schön M P, Zollner T M, Boehncke W H. J Invest Dermatol 2003: 121: 951-962.
27. Zhang J, Alcaide P, Liu L et al. PLoS ONE 2011: 6: e14525.
28. Schütz M, Teifel M, Friedl P. Eur J Cell Biol 1997: 74: 315-320.
29. Oostingh G J, Schlickum S, Friedl P et al. J Invest Dermatol 2007: 127: 2253-2258.
30. Zollner T M, Asadullah K. J Clin Invest 2003: 112: 980-983.
31. Yao L, Setiadi H, Xia L et al. Blood 1999: 94: 3820-3828.
32. Garcia-Caballero M, Mari-Beffa M, Medina M A et al. J Invest Dermatol 2011: 131: 1347-1355.
33. Gesser B, Johansen C, Rasmussen M K et al. J Invest Dermatol 2007: 127: 2129-2137.
34. Werdenberg D, Joshi R, Wolffram S et al. Biopharm Drug Dispos 2003: 24: 259-273.
35. Loewe R, Pillinger M, de Martin R et al. J Invest Dermatol 2001: 117: 1363-1368.
36. Loewe R, Holnthoner W, Groger M et al. J Immunol 2002: 168: 4781-4787.
37. Collins T, Read M A, Neish A S et al. FASEB J 1995: 9: 899-909.
38. Chen C C. Curr Pharm Des 2006: 12: 3497-3508.
39. Lawrence T. Cold Spring Harb Perspect Biol 2009: 1: a001651.
40. McKenzie R C, Sabin E. Exp Dermatol 2003: 12: 337-345.
41. Sen R, Smale S T. Cold Spring Harb Perspect Biol 2010: 2: a000257.
42. Mrowietz U, Asadullah K. Trends Mol Med 2005: 11: 43-48.
43. Gerdes S, Shakery K, Mrowietz U. Br J Dermatol 2007: 156: 838-842.
44. Marmon S, Cammer M, Raine C S et al. Exp Dermatol 2009: 18: 88-90.
45. Schottelius A J, Moldawer L L, Dinarello C A et al. Exp Dermatol 2004: 13: 193-222.